Flatiron Health Showcases AI-Driven Oncology Data at ISPOR 2026 — Flatiron Health, Inc.

Event summary

Flatiron Health will present 18+ research acceptances at ISPOR 2026, including seven authored posters and a panel discussion.
The company's VALID Framework for evaluating AI-extracted oncology data was recently published in the Journal of Clinical Oncology Clinical Cancer Informatics.
Research highlights include studies on prostate cancer progression, digital-twin modeling for lung cancer survival prediction, and real-world data-supported external-control arms.
ISPOR 2026 takes place from May 17-20, 2026, in Philadelphia.

The big picture

Flatiron Health's strong showing at ISPOR 2026 underscores the growing importance of AI and real-world data in oncology research. The company's VALID Framework represents a significant step towards standardizing data integrity in an industry increasingly reliant on machine learning. As healthcare systems globally seek more efficient and accurate methods for clinical decision-making, Flatiron's innovations position it as a key player in the evolving oncology intelligence landscape.

What we're watching

AI Integration: How Flatiron's AI-driven data validation methods will impact the adoption of real-world evidence in oncology research.
Regulatory Influence: Whether the VALID Framework will become an industry standard for evaluating AI-extracted healthcare data.
Market Positioning: The pace at which Flatiron can leverage its ISPOR 2026 presence to strengthen partnerships and expand its oncology intelligence ecosystem.